Miaoyan Du

机构：First Affiliated Hospital Zhejiang University

发表论文 4 篇 · 总被引 61 次 · h-index 3

代表论文

• HOTAIR/miR-1277-5p/ZEB1 axis mediates hypoxia-induced oxaliplatin resistance via regulating epithelial-mesenchymal transition in colorectal cancer (2022 · Cell Death Discovery · 被引 39)
• <p>Efficacy of Pyrotinib in a Heavily Pretreated Patient with Lung Adenocarcinoma Harboring HER2 Amplification and Exon 20 Insertions: A Case Report</p> (2020 · OncoTargets and Therapy · 被引 13)
• Optimizing perioperative treatment for potentially resectable stage III squamous cell lung carcinoma: promising results of a condensed four-cycle regimen with tislelizumaband chemotherapy (2024 · BMC Medicine · 被引 9)
• Perioperative camrelizumab plus apatinib and gemcitabine-oxaliplatin in patients with borderline resectable biliary tract malignancies: A multicenter, single-arm, phase II trial. (2025 · Journal of Clinical Oncology)